Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts

Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts

Submitted by admin on April 24, 2025 - 9:18pm
Source: 
Investors Business Daily
News Tags: 
Gilead Sciences
earnings
Biktarvy
Trodelvy
Headline: 
Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts
snippet: 

Two of Gilead Sciences' (GILD) most important drugs, Biktarvy and Trodelvy, missed Wall Street's sales expectations late Thursday. Gilead stock slumped in late trades.

Do Not Allow Advertisers to Use My Personal information